Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer
Applying to UT MD Anderson Cancer Center · Houston, Texas
Answer a few short questions to share with the research team.